Retrospective analysis study (n=102) on the use of CELOX PPH GAUZE as a treatment for PPH compared with current standard of care

Postpartum Haemorrhage:
CELOX™ PPH Gauze retrospective data analysis report (Charité data).

Henrich, W, Dückelmann A, Giroud D, Sarr Y. Version 1.1 – 19 May 2022.
Retrospective analysis study (n=102)

  • Assessment of 102 patients with PPH who did not respond to conventional treatments
  • Primary objective: to control uterine bleeding in PPH with CELOX™ PPH
  • CELOX™ PPH demonstrated 100% successful haemostasis in all patients with grade 1 and 2 bleeds (up to 2500mls) for all deliveries
  • CELOX™ PPH demonstrated 95.7% successful haemostasis in all patients with grade 1 to 3 bleeds (up to 8000mls) for vaginal deliveries
  • Following the introduction of CELOX™ PPH the incidence of hysterectomies was significantly reduced (versus standard of care) by 77.8%
Fast acting Safe and clinically effective Versatile and Easy to use
UK Office

Medtrade Products Ltd,
Electra House,
Crewe Business Park,
Crewe, Cheshire, England,

This website uses Cookies to improve your browsing experience and to help with our marketing. You can read more about removing Cookies here: Cookie Policy

I'm fine with this
Get In Touch

Get In Touch

We would like to hear from you. Please send us a message by filling out the form below and we will get back with you shortly.



Enquiry Type